Life Molecular Imaging
Rodrigo Teodoro is a CMC Manager for the Global License Network at Life Molecular Imaging since April 2021, where responsibilities include overseeing research and development in the field of radiopharmaceuticals. Prior to this role, Rodrigo served as a Research Collaborator at Helmholtz-zentrum Dresden-Rossendorf from October 2011 to April 2021, focusing on the development of new radiopharmaceuticals for brain imaging and standardizing radiosynthesis and analytical techniques. Earlier experience includes a position as a Research Collaborator at the Institute of Energetic and Nuclear Research from May 2005 to November 2011, where Rodrigo contributed to developing a Mo-99 production route. Rodrigo holds a PhD in chemistry, specializing in the design of biomolecules for early cancer diagnosis and quality control of radiopharmaceuticals, and earned a Bachelor’s degree in chemistry from Universidade Federal de Uberlândia between 2001 and 2005.
This person is not in any offices
Life Molecular Imaging
Life Molecular Imaging (formerly Piramal Imaging) is now part of the Alliance Medical Group, an integrated business including research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities. These combined services allow physicians, pharma industry and academia greater access to established and innovative imaging agents for clinical trials and clinical routine. With an ever increasing demand of effective care as well as a growing global awareness of healthcare efficiency and costs, improved diagnostic tools offer a unique opportunity for: - Earlier detection and better characterization of diseases - Determining the right therapy at the right dose for a patient (precision medicine) - Monitoring therapy response As a global leader in the field of radiopharmaceuticals, Life Molecular Imaging is developing a product portfolio of innovative molecular imaging probes that address major clinical needs in neurology, oncology, and cardiology. Life Molecular Imaging is supporting use of imaging biomarkers in several major therapeutic trials in Alzheimer’s disease. Imprint: Life Molecular Imaging GmbH Tegeler Strasse 6-7 13353 Berlin Germany Telefon: +49 30 461 124603 Fax: +49 30 461 124 629 Email: info@life-mi.com Internet: http://www.life-mi.com Managing Directors: Dr. Ludger Dinkelborg Michel Jongens Chamber of Commerce: Amtsgericht Charlottenburg HRB 136823 B Sales tax identification number: DE 283685037 Data Protection Policy: https://life-mi.com/data-protection/